Zobrazeno 1 - 10
of 1 251
pro vyhledávání: '"De Guibert S"'
Autor:
Oluwole OO; Vanderbilt University Medical Cancer Center, Nashville, TN, USA. olalekan.oluwole@vumc.org., Forcade E; Service d'Hématologie Clinique et Thérapie Cellulaire, Centre Hospitalier Universitaire de Bordeaux, F-33000, Bordeaux, France., Muñoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., de Guibert S; Hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France., Vose JM; University of Nebraska Medical Center, Omaha, NE, USA., Bartlett NL; Washington University School of Medicine and Siteman Cancer Center, St Louis, MO, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Deol A; Karmanos Cancer Center, Wayne State University, Detroit, MI, USA., McSweeney P; Colorado Blood Cancer Institute, Denver, CO, USA., Goy AH; John Theurer Cancer Center, Hackensack, NJ, USA., Kersten MJ; Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam (on behalf of HOVON/LLPC), The Netherlands., Jacobson CA; Dana-Farber Cancer Institute, Boston, MA, USA., Farooq U; University of Iowa, Iowa City, IA, USA., Minnema MC; University Medical Center Utrecht (on behalf of HOVON/LLPC), Utrecht, The Netherlands., Thieblemont C; Paris University, Assistance publique-Hôpitaux de Paris, Hemato-oncology, F-75010, Paris, France., Timmerman JM; University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA., Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Avivi I; Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Tzachanis D; University of California San Diego, La Jolla, CA, USA., Zheng Y; Kite, a Gilead Company, Santa Monica, CA, USA., Vardhanabhuti S; Kite, a Gilead Company, Santa Monica, CA, USA., Nater J; Kite, a Gilead Company, Santa Monica, CA, USA., Shen RR; Kite, a Gilead Company, Santa Monica, CA, USA., Miao H; Kite, a Gilead Company, Santa Monica, CA, USA., Kim JJ; Kite, a Gilead Company, Santa Monica, CA, USA., van Meerten T; University Medical Center Groningen, Groningen (on behalf of HOVON/LLPC), The Netherlands.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Mar; Vol. 59 (3), pp. 366-372. Date of Electronic Publication: 2024 Jan 04.
Autor:
Shadman M; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA., Munir T; Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Robak T; Copernicus Memorial Hospital, Medical University of Łódź, Łódź, Poland., Brown JR; Dana-Farber Cancer Institute, Boston, MA., Kahl BS; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO., Ghia P; Università Vita-Salute San Raffaele, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy., Giannopoulos K; Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland.; Hematology Department, St John's Cancer Centre, Lublin, Poland., Šimkovič M; 4th Department of Internal Medicine-Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Králové, Czech Republic., Österborg A; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden., Laurenti L; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Walker PA; Peninsula Health and Peninsula Private Hospital, Frankston, Melbourne, VIC, Australia., Opat SS; Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Ciepluch H; Department of Hematology, Copernicus Regional Oncology Centre, Gdansk, Poland., Greil R; Third Medical Department With Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Hanna M; Department of Haematology, Waitemata District Health Board, Takapuna, New Zealand., Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy., Trněný M; First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic., Brander D; Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC., Flinn IW; Tennessee Oncology/OneOncology, Nashville, TN., Grosicki S; Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland., Verner E; Concord Repatriation General Hospital, Concord, NSW, Australia.; University of Sydney, Sydney, NSW, Australia., Tedeschi A; Department of Hematology, Azienda Socio Sanitaria Territoriali Grande Ospedale Metropolitano Niguarda, Milan, Italy., de Guibert S; Hôpital de Pontchaillou, Rennes, France., Tumyan G; Department of Chemotherapy of Hemoblastosis, Blokhin Russian Cancer Research Center, Moscow, Russia., Laribi K; Hematology Department, Centre Hospitalier du Mans, Le Mans, France., García-Marco JA; Unidad de Citogenetica Molecular, Servicio de Hematología, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Li JY; The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Tian T; BeiGene USA, Inc, San Mateo, CA., Liu Y; BeiGene USA, Inc, San Mateo, CA., Korolkiewicz R; BeiGene USA, Inc, San Mateo, CA., Szeto A; BeiGene USA, Inc, San Mateo, CA., Tam CS; Alfred Health and Monash University, Melbourne, VIC, Australia., Jurczak W; Maria Skłodowska-Curie National Research Institute of Oncology, Kraków, Poland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 08, pp. JCO2402265. Date of Electronic Publication: 2024 Dec 08.
Autor:
Guièze R; CHU Clermont-Ferrand, Service de Thérapie Cellulaire et d'Hématologie Clinique, Clermont-Ferrand, France. rguieze@chu-clermontferrand.fr.; Université Clermont Auvergne, Unité de Recherche 7453 (CHELTER), Clermont-Ferrand, France. rguieze@chu-clermontferrand.fr., Ysebaert L; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse, 1 Avenue Irene Joliot-Curie, 31059, Toulouse, France., Roos-Weil D; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France., Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France., Ferrant E; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie Clinique, Pierre-Bénite, France., Molina L; University Hospital Grenoble Alpes, Grenoble, France., Aurran T; Institut Paoli-Calmettes, Hématologie, Marseille, France., Clavert A; Service des Maladies du Sang, CHU Angers, Angers, France., de Guibert S; Service d'Hématologie Clinique, CHU Rennes, Rennes, France., Michallet AS; Service d'Hématologie, Centre Léon Bérard, Lyon, France., Saad A; Haematology Department, Hospital Center of Beziers, Beziers, France., Drénou B; Department of Hematology, CH Mulhouse, Mulhouse, France., Quittet P; Département d'Hématologie, CHU Montpellier, Montpellier, France., Hivert B; Hématologie Clinique, Groupement des Hôpitaux de l'Institut Catholique de Lille Hôpital St Vincent de Paul, Lille, France., Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France., Gay J; Service d'Hématologie, Centre Hospitalier de la Côte Basque, Bayonne, France., Quinquenel A; Department of Hematology, University Hospital of Reims, UFR Médecine, Reims, France., Broseus J; CHRU-Nancy, Service d'Hématologie Biologique, Pôle Laboratoires, F54000, Nancy, France.; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France., Rouille V; French Innovative Leukemia Organization, Tours, France., Schwartz D; French Innovative Leukemia Organization, Tours, France., Magnin B; Department of Radiology, CHU Clermont-Ferrand, Clermont-Ferrand, France., Lazarian G; Laboratoire d'hématologie, HUPSSD, Hôpital Avicenne, Bobigny, France., Véronèse L; Université Clermont Auvergne, Unité de Recherche 7453 (CHELTER), Clermont-Ferrand, France.; Service de Cytogénétique, CHU de Clermont-Ferrand, Clermont-Ferrand, France., de Antonio M; Department of Statistics, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Laurent C; Département de Pathologie, Institut Universitaire du Cancer, Centre Hospitalo-Universitaire (CHU) de Toulouse, Toulouse, France., Tournilhac O; CHU Clermont-Ferrand, Service de Thérapie Cellulaire et d'Hématologie Clinique, Clermont-Ferrand, France.; Université Clermont Auvergne, Unité de Recherche 7453 (CHELTER), Clermont-Ferrand, France., Pereira B; Department of Statistics, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; CHRU Nancy, Service d'hématologie clinique adulte, Nancy, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 09; Vol. 15 (1), pp. 6822. Date of Electronic Publication: 2024 Aug 09.
Autor:
van Meerten T; Department of Haematology, University Medical Center Groningen Groningen, The Netherlands., Kuruvilla J; Princess Margaret Cancer Centre Toronto, ON, Canada., Song KW; Vancouver General Hospital, BC Cancer, The University of British Columbia Vancouver, BC, Canada., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hemato-Oncology, Hôpital Saint-Louis, Paris University Paris, France., Minnema MC; Department of Haematology, University Medical Center Utrecht Utrecht, The Netherlands., Forcade E; CHU Bordeaux, Service d'Hematologie et Thérapie Cellulaire Bordeaux, France., De Guibert S; Hématologie Clinique, CHU Rennes Rennes, France., Kersten MJ; Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam Amsterdam, The Netherlands., Mutsaers PG; Department of Hematology, Erasmus University Medical Center Rotterdam, The Netherlands., Wermke M; TU Dresden Medizinische Fakultät Carl-Gustav Carus, NCT/UCC Early Clinical Trial Unit/Medizinische Klinik I Dresden, Germany., Zheng Y; Kite, a Gilead Company Santa Monica, CA, USA., Xue A; Kite, a Gilead Company Santa Monica, CA, USA., Winters JN; Kite, a Gilead Company Santa Monica, CA, USA., Nater J; Kite, a Gilead Company Santa Monica, CA, USA., Shen RR; Kite, a Gilead Company Santa Monica, CA, USA., Spooner C; Kite, a Gilead Company Santa Monica, CA, USA., Neumann F; Kite, a Gilead Company Santa Monica, CA, USA., Kim JJ; Kite, a Gilead Company Santa Monica, CA, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg Würzburg, Germany.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2024 Jun 15; Vol. 14 (6), pp. 2905-2920. Date of Electronic Publication: 2024 Jun 15 (Print Publication: 2024).
Autor:
Mauget M; Department of Hematology, University Hospital of Rennes, Rennes, France.; Department of Infectious Diseases and Intensive Care Unit, University Hospital of Rennes, Rennes, France., Lemercier S; Department of Neurology, University Hospital of Rennes, Rennes, France., Quelven Q; Department of Infectious Diseases and Intensive Care Unit, University Hospital of Rennes, Rennes, France., Maamar A; Department of Infectious Diseases and Intensive Care Unit, University Hospital of Rennes, Rennes, France., Lhomme F; Department of Hematology, University Hospital of Rennes, Rennes, France., De Guibert S; Department of Hematology, University Hospital of Rennes, Rennes, France., Houot R; Department of Hematology, University Hospital of Rennes, Rennes, France.; INSERM, U1236, Rennes, France., Manson G; Department of Hematology, University Hospital of Rennes, Rennes, France.
Publikováno v:
Blood advances [Blood Adv] 2024 May 28; Vol. 8 (10), pp. 2491-2498.
Autor:
Perthus A; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Colin F; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Charton E; Human and Social Sciences Department Leon Berard Center Lyon France., Anota A; Human and Social Sciences Department Leon Berard Center Lyon France.; Department of Clinical Research and Innovation Leon Berard Center Lyon France., Lhomme F; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Manson G; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., De Guibert S; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Daufresne P; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Bellec A; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., Le Bars L; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France., De Barros S; Department of Hematology Cancer University Institute of Toulouse Oncopole Toulouse France., Ysebaert L; Department of Hematology Cancer University Institute of Toulouse Oncopole Toulouse France., Merceur M; Department of Physical and Rehabilitation Medicine University Hospital of Rennes Rennes France., Cogné M; Department of Physical and Rehabilitation Medicine University Hospital of Rennes Rennes France., Lamy De La Chapelle T; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France.; UMR U1236, INSERM University of Rennes Rennes France., Houot R; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France.; UMR U1236, INSERM University of Rennes Rennes France., Moignet A; Service d'Hématologie-CHU Pontchaillou, Department of Hematology University Hospital of Rennes Rennes France.
Publikováno v:
HemaSphere [Hemasphere] 2024 May 27; Vol. 8 (5), pp. e72. Date of Electronic Publication: 2024 May 27 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dupuis, J., Brice, P., François, S., Ysebaert, L., de Guibert, S., Levy, V., Leprêtre, S., Choquet, S., Dilhuydy, M.S., Fornecker, L., Morel, V., Tempescul, A.
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia February 2015 15(2):e43-e46
Autor:
Doncker, A.-V., Balabanian, K., Bellanné-Chantelot, C., de Guibert, S., Revest, M., Bachelerie, F., Lamy, T.
Publikováno v:
In Clinical Microbiology and Infection February 2011 17(2):135-139
Autor:
Michallet AS; Department of Hematology, Centre Léon Bérard, Lyon, France., Letestu R; Hematology Laboratory, Avicenne Hospital, Hôpitaux universitaires Paris Seine Saint-Denis (HUPSSD), Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France., Le Garff-Tavernier M; Department of Hematology Biology, AP-HP, Hôpital Pitié Salpêtrière, Paris, France., Campos L; Department of Hematology Biology, Le Centre Hospitalier Universitaire (CHU) Saint Etienne, Saint Etienne, France., Ticchioni M; Department of Immunology, CHU Nice, Nice, France., Dilhuydy MS; Department of Hematology, CHU Bordeaux, Pessac, France., Morisset S; Department of Hematology, Centre Léon Bérard, Lyon, France., Rouille V; Department of Hematology, CHU Montpellier, Montpellier, France., Mahé B; Department of Hematology, Nantes University Hospital, Nantes, France., Laribi K; Department of Hematology, CH Le Mans, Le Mans, France., Villemagne B; Department of Hematology, CHD Vendée, La Roche-sur-Yon, France., Ferrant E; Department of Hematology and Oncology, CH Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, Pierre-Benite, Lyon, France., Tournilhac O; Department of Hematology and Cellular Therapy, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France., Delmer A; Department of Hematology, CHU Reims, Reims, France., Molina L; Department of Hematology, CHU Grenoble, La Tronche, France., Leblond V; Department of Hematology, AP-HP, Hôpital Pitié Salpêtrière, Paris, France., Tomowiak C; Department of Hematology, CHU Poitiers, Poitiers, France., de Guibert S; Department of Hematology, CHU Rennes, Rennes, France., Orsini-Piocelle F; Hematology Service, CH Annecy, Annecy, France., Banos A; Department of Hematology, CH Côte Basque, Bayonne, France., Carassou P; Department of Hematology, CH Metz, Metz, France., Cartron G; Department of Hematology, CHU Montpellier, Montpellier, France.; Department of Hematology, Montpellier University Hospital, Montpelllier, France., Fornecker LM; Department of Hematology, Strasbourg University Hospital, Strasbourg, France., Ysebaert L; Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Dartigeas C; Department of Hematology, CHU Tours, Hôpital Bretonneau, Tours, France., Truchan-Graczyk M; Department of Hematology, CHU Angers, Angers, France., Vilque JP; Institut d'Hématologie de Basse-Normandie, Centre François Baclesse, Caen, France., Schleinitz TA; Department of Hematology, Institut Paoli Calmettes, Marseille, Marseille France., Cymbalista F; Department of Hematology, Avicenne Hospital, HUPSSD, AP-HP, Bobigny, France., Leprêtre S; Inserm U1245 and Department of Hematology, Centre Centre Henri-Becquerel and Normandie University UNIROUEN, Rouen, France., Lévy V; Department of Clinical Research, Avicenne Hospital, HUPSSD, AP-HP, Bobigny, France., Nguyen-Khac F; Department of Hematology, AP-HP, Hôpital Pitié Salpêtrière, Paris, France., Feugier P; Department of Hematology, Centre Hospitalier Régional Universitaire de Nancy, Hôpitaux de Brabois, Vandoeuvre-lès-Nancy, France.
Publikováno v:
Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 3936-3945.